位置：成果数据库 > 期刊 > 期刊详情页
Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance..
  • ISSN号：0008-5472
  • 期刊名称：Cancer Research
  • 时间：2010.2.2
  • 页码：154-161
  • 相关项目：克服ABC药物转运泵介导肿瘤细胞多药抗药性的新策略
作者： Hopper-Borge E|Tiwari AK|Tiwari AK|Lee JW|Lee JW|Fu LW|Fu LW|Chen ZS|Chen ZS|
同期刊论文项目
克服ABC药物转运泵介导肿瘤细胞多药抗药性的新策略
期刊论文 12
同项目期刊论文
Effect of Dicycloplatin, a Novel Platinum Chemotherapeutical Drug, on Inhibiting Cell Growth and Ind
Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-B
Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of
Apatinib (YN968D1) enhances the efficacy of conventional chemotherapeutical drugs in side population
Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vi
Axitinib Targeted Cancer Stem like Cells to Enhance Efficacy of Chemotherapeutic Drugs via Inhibitin